Texas Society of Clinical Oncology (TxSCO) Annual Conference - 10/26/2021

The field of oncology is rapidly evolving with the constant release of new cancer-related research. Health care professionals who care for patients with cancer can find it challenging to stay update to date with the latest best practices in cancer care. They may not be aware of the growing number of ways that immunotherapy and targeted therapies are revolutionizing care for patients with a variety of different cancers, including lung cancer and kidney cancer. In particular, chimeric antigen receptor (CAR)-T cell therapy, a revolutionary advance that harnesses T cells to fight cancer, is providing hope for treating some types of cancer that no longer respond to other treatments. 

 

Target Audience

Pharmacists, Physician Assistants, Nurses, and Nurse Practitioners who are interested in the field of Oncology

Learning Objectives

At the conclusion of this activity, participants will be able to:

  1. Summarize new research and best practices for treating lung cancer.  

  1. Use new knowledge about the role of immunotherapy in managing kidney cancer.  

  1. Describe the latest innovations in the use of CAR T-cell therapies.  

Course summary
Available credit: 
  • 2.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 2.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 2.00 ANCC
  • 2.00 Participation
Course opens: 
10/26/2021
Course expires: 
10/26/2022
Rating: 
0

5:00 PM         Updates in Lung Cancer   

                     Kartik Konduri, MD  

                     Texas Oncology at Baylor Charles A. Sammons Cancer Center  

 

5:40 PM        Innovations in CAR T-Cell Therapies  
                      Larry Anderson, MD, PhD  

                      UT Southwestern Medical Center  

  

6:20 PM        Current Immunotherapy Landscape in Renal Cell Carcinoma   
                      Gury Doshi, MD  

                                Texas Oncology at Baylor Charles A. Sammons Cancer Center   

 

7:00 PM        Closing Remarks  

*This program is subject to change

Kartik Konduri, MD  

Texas Oncology at Baylor Charles A. Sammons Cancer Center

 

Larry Anderson, MD, PhD  

UT Southwestern Medical Center  

 

Gury Doshi, MD  

Texas Oncology at Baylor Charles A. Sammons Cancer Center 

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Boston University School of Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Attendees should claim only the credit commensurate with the extent of their participation in the activity.

 

Available Credit

  • 2.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 2.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 2.00 ANCC
  • 2.00 Participation
Please login or register to take this course.

Registration Fees:

MD/DO - $795

Allied Health Professions/Technicians - $550

Fellows/Residents - $395


BUSM/BMC Alumni and Faculty/Staff discounts are available

BUSM CME complies with the ADA and the rules and regulations thereof to make reasonable accommodations for our educational activities. If any participant in this educational activity is in need of accommodations, please contact BUSM CME at cme@bu.edu.

The CME office will work to accommodate dietary requests (including, but not limited to: vegetarian, kosher, low cholesterol, and low-sodium meals) received, in writing, at least two weeks prior to the start of the conference.

Cancellation Policy:

Substitutions may be made at any time without an additional charge.  Refunds, less an administrative fee of $75, will be issued for all cancellations received two weeks prior to the start of the conference.  Should cancellation occur within the two-week window, a credit will be issued, not a refund.  Credits will be honored for up to two years.  “No shows” are subject to the full course fee.  Cancellations/substitution(s) must be made in writing.  Refunds or credits will not be issued once the conference has started.  This course is subject to change or cancellation.

If you need to cancel your registration, please click here. 

We will follow state and federal COVID-19 guidelines.  All attendees will be required to wear masks.